RESUMO
Nobiletin (NOB), the major bioactive component of polymethoxyflavones in citrus fruits, has been reported possessing significant biological properties. The purpose of the present study was to investigate the protective role of NOB on lipopolysaccharide (LPS)-induced endotoxic shock in mice. We found pretreatment with NOB increases the survival rate of mice after endotoxin injection. The present study clearly demonstrates that pretreatment with NOB decreases the production of early pro-inflammatory cytokines TNF-α, IL-6, and late-phase mediator HMGB1 in serum and tissues of kidney, lung, and liver. The histopathological study indicates that NOB administration significantly attenuate tissues injury induced by LPS. Moreover, NOB suppresses the activity of nuclear factor-kappa B (NF-κB). These results suggest that NOB protects mice against LPS-induced endotoxic shock through inhibiting the production of TNF-α, IL-6, and HMGB1 and the activation of NF-κB, which elucidate that NOB may be a promising drug candidate for the treatment of septic shock.
Assuntos
Flavonas/uso terapêutico , Proteína HMGB1/antagonistas & inibidores , Interleucina-6/antagonistas & inibidores , NF-kappa B/metabolismo , Choque Séptico/prevenção & controle , Fator de Necrose Tumoral alfa/antagonistas & inibidores , Animais , Flavonas/efeitos adversos , Proteína HMGB1/sangue , Interleucina-6/sangue , Rim/patologia , Lipopolissacarídeos/toxicidade , Fígado/patologia , Pulmão/patologia , Macrófagos/imunologia , Masculino , Camundongos , Choque Séptico/tratamento farmacológico , Fator de Necrose Tumoral alfa/sangueRESUMO
We report a case of thrombocytopenic purpura associated with the intake of two dietary supplements containing mainly citrus flavonoids. This is the first case to be notified to the French Agency for Food, Environmental and Occupational Health Safety (ANSES). It addresses the importance of an accurate medication history interview for each patient.
Assuntos
Adjuvantes Imunológicos/efeitos adversos , Fármacos Antiobesidade/efeitos adversos , Citrus/química , Suplementos Nutricionais/efeitos adversos , Flavanonas/efeitos adversos , Flavonas/efeitos adversos , Hesperidina/análogos & derivados , Medicamentos sem Prescrição/efeitos adversos , Púrpura Trombocitopênica/induzido quimicamente , Corticosteroides/uso terapêutico , Hesperidina/efeitos adversos , Humanos , Imunoglobulinas Intravenosas/uso terapêutico , Masculino , Pessoa de Meia-Idade , Transfusão de Plaquetas , Púrpura Trombocitopênica/terapiaRESUMO
BACKGROUND: The detection of molecular targets for flavonoids in cell signalling has opened new perspectives for their application in medicine. Both tangeretin, a citrus methoxyflavone, and xanthohumol, the main prenylated chalcone present in hops (Humulus lupulus L.), act on the mitogen-activated protein kinase pathway and await further investigation for administration in vivo. MATERIALS AND METHODS: A safety study was designed in laboratory mice orally administered concentrates of purified tangeretin (1 x 10(-4) M) or xanthohumol (5 x 10(-4) M) at libitum for 4 weeks. Blood samples were collected for the analysis of a variety of haematological and biochemical parameters. RESULTS: A reduction of the circulating lymphocyte number was noticed for tangeretin, while all other parameters were unaffected by treatment with either tangeretin or xanthohumol. The parameters encompassed an integrity check of the following tissues and organs: bone marrow, liver, exocrine pancreas, kidneys, muscles, thyroid, ovaries and surrenal cortex. Furthermore, no differences were noted in the metabolism of proteins, lipids, carbohydrates and uric acid, as well as in ion concentrations. CONCLUSION: All data indicate that oral administration of tangeretin or xanthohumol to laboratory mice does not affect major organ functions and opens the gate for further safety studies in humans.